Startup Of Home-Based IUI Treatment Pivoted To Copper Face Mask In Pandemic Times

The CORONA pandemic has affected many companies and industry growth by dropping them in the loss. The company has pivoted and determined to grow with hard endeavour. Such persistence gifts them revenue-generating growth where others are struggling to find it. 

As the time demands,of the crucial defence against COVID-19. The company turned to design a face mask. It is not ordinary. Vikram Rajput, Founder of medical device startup Subhag HealthTech, The copper-infused face mask which is named "VSafe" is one of the protection assuring mask, as copper is considered a naturally antimicrobial material and is presumed to be more resistant to coronavirus.

They started offering our IUI solution in Bangalore since last year through trained nurses because the concept of self-administration is still new in India. But the process blocked due to lockdown.  

The copper masks not only maintained the revenue expansion but also helped the startup to build and stabilize a trusted distribution network for portable IUI device VConceive.

According to him, four distributors joined together to launch Vconceive as per now and including India, V-safe is exported to ICICI London,  Dubai, Singapore and will soon reach to the US. Both products have been launched on Amazon. 

“I am proud to say that we have developed a medical device on an affordable budget,” says Vikram. He adds-During the pandemic, the startup has been reasonable in terms of its operations. Since they formally launched V-safe in February, revenue has increased by 200 per cent. He confided that - “Last month, we sold 600 units of conceiving, next plan is to sell 5,000 units per month.

He believes that the startup will be able to achieve the target. According to him, they will add up to a revenue vision of Rs 20-Rs 25 crores in the next year.

V-CONCEIVE for infertility 

Aided reproductive technologies are becoming popular the world over. It is estimated that the global fertility services market size will be expanded by 8.5 % by 2023 (according to Market Research Future report). In India, infertility influences about 10 to 14 % of the population, with higher rates in urban areas where one out of six couples is impacted (according to data from the Indian Society of Assisted Reproduction).

The startup originated by Vikram personal pain levels as he and his wife suffered each stage when they were planning for a baby. Availability of many infertility treatment markets, according to Vikram, “ their products helps to get rid of unfair care provider dominance, lack of transparency to patients, the tediousness of the treatment delivery, and extremely high costs making the treatment unaffordable to a vast majority of the target population”. Subhag aims to bring all infertility treatment-related services on a single platform by providing online consultation with doctors.

•  tests were done at the customer’s convenience.
•  perform IUI at home.
•  receive recommendations to best infertility centres.
•  make the whole journey more credible and efficient.

Vikram and his Korean-German Co-founder and CTO JI Kwang Jeong are based in Berlin, claims a success rate of 20 % per cycle for the first three tries, Vikram claims that IUI is in no way an alternative to IVF treatment. However, it certainly helps couples who may have no other option but to go with the costlier IVF treatment. The startup came up with two products after three years of R&D- home insemination kit VConceive and sperm washing device Androwash.